What Are Your Options for Hormone Therapy? A Physician’s Guide
Hormone therapy isn’t one-size-fits-all. Here’s a clear breakdown of your options — from patches to pills to vaginal estrogen — and how a physician actually decides between them.
When women start researching hormone therapy, they often hit a wall of conflicting information, brand names they don’t recognize, and recommendations that seem to contradict each other depending on the source. Part of what makes this confusing is that hormone therapy is not a single thing. It’s a category of treatment with multiple delivery methods, formulations, and dosing approaches — and the variation exists for good reason.
Here’s how I actually think through these options with patients.
What is hormone therapy?
Hormone therapy refers to the use of estrogen, progesterone, or both to address the hormonal decline that occurs during perimenopause and menopause. The goal is to restore a level of hormonal balance that supports symptom relief, quality of life, and in many cases long-term health. What works well for one woman may not be the right fit for another — which is exactly why the evaluation process matters.
What are the options for estrogen?
Estrogen is the primary driver of most perimenopausal and menopausal symptoms, and it has the most delivery options.
Patches deliver estrogen through the skin directly into the bloodstream, bypassing the digestive system. This transdermal route is associated with a lower risk of blood clots compared to oral estrogen — a meaningful distinction for women with certain risk factors. Patches are changed on a schedule, typically once or twice a week.
Oral tablets deliver estrogen through the digestive system, where the liver processes it before it enters the bloodstream. The liver processing does affect how it interacts with other systems in the body, which factors into dosing and risk assessment for some women. But for many women, depending on individual health and risk factors, oral estrogen may be a safe and effective option.
Both patches and oral tablets address systemic symptoms: hot flashes, night sweats, mood changes, sleep disruption, brain fog, and vaginal dryness when significant.
What is vaginal estrogen and who is it for?
Vaginal estrogen is its own category, and it’s frequently misunderstood.
Available as creams, rings, and dissolvable tablets, vaginal estrogen delivers estrogen locally to vaginal tissue rather than systemically. Because absorption into the bloodstream is minimal, it carries a different risk profile than systemic estrogen. It does not address hot flashes or other full-body symptoms. What it does address are vaginal symptoms specifically: dryness, thinning of vaginal tissue, discomfort during intercourse, and recurrent urinary tract infections related to tissue changes.
In practice, most women don’t come in describing vaginal dryness as their only complaint. They come in with hot flashes, sleep disruption, mood changes — and vaginal symptoms may be part of the picture too. In those cases, systemic estrogen is the more appropriate treatment, and it will generally also help vaginal symptoms. Vaginal estrogen on its own is best suited for women whose primary or only concern is vaginal — and for those patients, it’s a targeted, well-tolerated option.
Why do women with a uterus need progesterone?
Any woman with a uterus who takes systemic estrogen also needs progesterone. Estrogen alone can cause the uterine lining to thicken, which increases the risk of uterine cancer. Progesterone provides protection against that effect.
But progesterone also has independent benefits worth knowing about. Oral progesterone has a documented sedative effect — it binds to GABA receptors in the brain and supports sleep quality. It also has a calming influence on the nervous system. For many women, it’s not just a necessary addition to estrogen therapy. It’s a meaningful contributor to how they feel day to day.
Combination tablets that deliver both estrogen and progesterone together are available for women who prefer a single daily pill.
What about testosterone?
Women produce testosterone in smaller amounts than men, and it also declines with age. Low testosterone in women is associated with low libido, fatigue, and reduced motivation. It’s not a standard component of most hormone therapy protocols, but it is used in individualized cases — particularly for sexual wellness concerns. Any use should be individualized and carefully supervised.
How does a physician actually decide between these options?
A good hormone therapy evaluation starts with the full picture: which symptoms are most disruptive, what your health history looks like, what your risk factors are, and how you prefer to take medication. A woman with a history of migraines may be prescribed a patch rather than a tablet. A woman whose primary complaint is vaginal symptoms needs a different conversation than one whose main issues are hot flashes and sleep disruption.
Dosing is individualized and adjusted over time. The goal is the lowest dose that achieves meaningful symptom relief — and many women need titration to get there. There’s a lot of wiggle room in finding what works, which is exactly why this needs to be provider-guided rather than static.
Timing also matters. Evidence suggests that hormone therapy started closer to the onset of menopause, rather than years later, is associated with better cardiovascular and cognitive outcomes. This is sometimes called the “window of opportunity.” It’s a reason to have the conversation earlier rather than waiting until symptoms become severe.
Are there non-hormonal options?
For women who aren’t candidates for hormone therapy — due to certain hormone-sensitive cancers or other contraindications — or who prefer not to use it, non-hormonal options exist for specific symptoms. For hot flashes, certain antidepressants and a newer medication class called neurokinin B antagonists have evidence for effectiveness. For vaginal symptoms, non-hormonal moisturizers and lubricants provide relief, though they don’t address underlying tissue changes the way estrogen does.
Non-hormonal approaches are legitimate. They work best when matched carefully to the specific symptoms someone is experiencing, not applied as a blanket alternative to everything hormone therapy addresses.
The most important thing to understand about all of these options is that the right answer is not the same for every woman. Your risk profile, your symptoms, your preferences, and your health history all shape what makes sense. You deserve a full explanation of the reasoning behind whatever is recommended — and if you’re not getting that, it’s worth asking for it.
Dr. Jessica Duncan is the Chief Medical Officer at Ivim Health, a physician-led virtual metabolic health company operating across 49 states. She is board-certified in obesity medicine and has published peer-reviewed research on GLP-1 outcomes in Obesity Pillars.
Disclaimer:
Medical Advice: This content is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider regarding your health needs, diagnosis, and medication management.
